v3.25.1
Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 08, 2023
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Oct. 31, 2024
Cash equivalents   $ 0   $ 0   $ 0
FDIC insured amount   250,000   250,000    
Uninsured cash   1,555,702   1,555,702   3,652,300
Allowance for credit losses   0   0   0
Accrued liabilities   0   0   46,775
Inventory reserves   0   0   313,654
Impairment, Long-Lived Asset, Held-for-Use       $ 0 $ 0  
Description of royalty rate       Royalty Rate. The royalty paid by PMPSA to KBI will no longer be based on sales price of the Product being sold, but rather on the volume of liquid contained within Product being sold. The royalty will be on a sliding scale of between $0.08 to $0.16 per sale based on the volume of liquid contained in the Product, increasing to between $0.10 to $0.20 per sale upon meeting certain sales milestones.    
License fees   90,000   $ 198,215    
License Agreement description       As of April 30, 2025, amounts receivable from PMPSA in connection with the PMI License Agreement totaled $70,000 of which $70,000 and $0 pertain to royalties and reimbursement of certain non-recurring engineering costs, respectively. As of October 31, 2024, amounts receivable from PMPSA in connection with the PMI License Agreement totaled $263,367 of which $263,367 and $0 pertain to royalties and reimbursement of certain non-recurring engineering costs, respectively.    
Bidi [Member]            
Concentration Risk Percentage         20.00%  
G P M Investments L L C [Member]            
Concentration Risk Percentage         15.00%  
Bidi [Member]            
License fees   $ 35,000 $ 60,000 $ 35,000 $ 60,000 $ 131,683
Revenue from the sale         998,905  
G P M Investments L L C [Member]            
Revenue from the sale         $ 763,562  
PMPSA [Member] | PMI License Agreement [Member]            
Royalty payment received $ 134,981